JWC3 I agree the Alzheimer’s results “release” will be a blue sky event. Im not sure that will be the $1249 point but if we look at Biogens MC after releasing sub par results and just take one 20 billion example and equate that into share price we are sitting at about $260. Multiply that x 2 with stellar results and a partnership announcement as the shares become very highly sought after! This is not even factoring small share price runs due to Rett Syndrome or other positive trial results./approval.
We have a chance with forward looking PE with in a few years to reach stellar moonshot highs! Dr Missling just needs to keep steadily moving forward as the storm brews against us!
Market Data 
Markets 
AI
